India's clinical research ambitions need more than regulatory reforms: Experts

At the latest Indian Pharma Post E-Conference, leading experts highlighted the need for accredited trial sites, skilled investigators, digital ecosystems, and greater public trust

Girish Bhunje appointed Senior Vice President – API Operations at Intas Pharmaceuticals

Intas Pharmaceuticals has appointed Girish Bhunje as Senior Vice President – API Operations

Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit

Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility

Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System

Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery

Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority

The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing

Frontage Laboratories expands China presence with Teddy Lab acquisition

Budget 2026 -27: Pharma sector cheers Rs. 10,000 crore Biopharma plan

The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave

FDA completes inspection of SMS Pharma’s Vizag facility

The inspection concluded with one minor observation in Form 483

Briefs: IOL Chemicals & Pharmaceuticals, Ipca Laboratories and Anuh Pharma

Ipca Laboratories receives three observations from USFDA for API facility at Tarapur